subject: UNII:41TIZ5663Z

object_name: myopathy, lactic acidosis, and sideroblastic anemia


subject: UNII:41TIZ5663Z

object_name: multiple system atrophy

tested_intervention: yes


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: coronary artery disorder

tested_intervention: unsure


subject: CHEBI:6503

object_name: coronary atherosclerosis


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: abdominal aortic aneurysm


subject: CHEBI:39548

object_name: aortic aneurysm, familial abdominal, 1


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Disorder related to renal transplantation


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Lacunar stroke


subject: PUBCHEM.COMPOUND:18140

object_name: prostate neoplasm


subject: CHEBI:4868

subject_name: Estramustine


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix

object_name: Androgen excess


subject: UMLS:C2000258

object_name: adult lymphoma


subject: UMLS:C2000258

object_name: lymphoma


subject: UMLS:C2000258

object_name: pediatric lymphoma


subject: UMLS:C2000258

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C2000258

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4650509

subject_name: MIBAVADEMAB

object_name: congenital generalized lipodystrophy


subject: CHEMBL.COMPOUND:CHEMBL4650509

object_name: generalized lipodystrophy


subject: UMLS:C5449393

subject_name: Mibavademab


subject: UMLS:C5449393


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Nutritional and Metabolic Diseases


subject: CHEBI:49040

object_name: endocrine system disorder


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:27470

subject_name: Folic acid

object_name: infertility


subject: CHEBI:24848

subject_name: inositol


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Edema


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: invasive aspergillosis


subject: UMLS:C4727312

subject_name: 6 Melanoma Helper Peptide Vaccine

object_name: ocular melanoma


subject: UMLS:C4727312

object_name: uveal melanoma


subject: UNII:OWK8BG0FO6


subject: UNII:OWK8BG0FO6


subject: UMLS:C4725831

subject_name: Anti-CD40 Agonist Monoclonal Antibody CDX-1140


subject: UMLS:C4725831


subject: PUBCHEM.COMPOUND:136033680

subject_name: Poly(ICLC)


subject: PUBCHEM.COMPOUND:136033680


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UMLS:C5856111

subject_name: HBV mRNA Vaccine

object_name: liver cancer


subject: UMLS:C5856111

object_name: liver neoplasm


subject: UMLS:C5856111

object_name: Adult Liver Carcinoma


subject: PR:000017503

subject_name: solute carrier family 53 member 1

object_name: alcohol abuse


subject: PR:000017503

object_name: alcohol dependence


subject: PR:000006336

subject_name: L-xylulose reductase


subject: PR:000006336


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: transitional cell carcinoma


subject: CHEBI:174615

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:174615

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:174615

object_name: Acute leukemia in remission


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: chronic myelomonocytic leukemia


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: myelofibrosis


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C1571394

object_name: Crohn disease


subject: CHEBI:94187

subject_name: Givinostat


subject: CHEBI:9150

subject_name: Simvastatin

object_name: uterine fibroid


subject: CHEBI:9150

object_name: leiomyoma


subject: UMLS:C3274554

subject_name: Fluorine F 18 RGD-K5

object_name: Carcinoma breast stage IV


subject: UMLS:C3274554

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Sodium valproate adverse reaction


subject: UMLS:C4708389

subject_name: Valproate sodium 500 mg prolonged-release oral tablet

object_name: epilepsy


subject: UMLS:C4708389


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:41J7ZJ239R

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:16359

subject_name: Cholic Acid

object_name: inborn disorder of bile acid synthesis


subject: CHEBI:8707

subject_name: Quetiapine

object_name: panic disorder


subject: CHEBI:8707

object_name: panic disorder 1


subject: CHEBI:8707

object_name: dysthymic disorder


subject: CHEBI:3223

subject_name: Buspirone

object_name: schizoaffective disorder


subject: CHEBI:3223

object_name: schizophrenia 18


subject: CHEBI:63005

subject_name: Sodium nitrate

object_name: Becker muscular dystrophy


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: poorly differentiated malignant neuroendocrine carcinoma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:72317

object_name: Carcinoma of the prostate stage III


subject: CHEBI:72317

object_name: Stage III Prostate Cancer AJCC v6


subject: UNII:0DE9724IHC

subject_name: Protamine

object_name: aortic valve disease 2


subject: UNII:0DE9724IHC

object_name: aortic stenosis


subject: UNII:0DE9724IHC

object_name: aortic valve disease 3


subject: UNII:0DE9724IHC

object_name: Stenosis of aorta


subject: UNII:0DE9724IHC

object_name: heart valve disorder


subject: PUBCHEM.COMPOUND:53395091

object_name: erythrocyte glutathione deficiency


subject: PUBCHEM.COMPOUND:53395091

object_name: Paresis


subject: PUBCHEM.COMPOUND:53395091

object_name: Muscle weakness


subject: CHEBI:16375

subject_name: D-Cysteine


subject: CHEBI:16375


subject: CHEBI:16375


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: CHEBI:17561


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: post-thrombotic syndrome


subject: PUBCHEM.COMPOUND:22976653

object_name: Deep vein thrombosis of lower limb


subject: PUBCHEM.COMPOUND:22976653

object_name: Deep venous thrombosis


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: PR:000012825


subject: UMLS:C3827085

object_name: glioblastoma


subject: UMLS:C3827085

object_name: Brain Stem Glioblastoma


subject: UMLS:C3827085

object_name: glioma susceptibility 1


subject: CHEBI:94805

subject_name: Ataluren

object_name: colorectal cancer


subject: CHEBI:94805

object_name: colorectal carcinoma


subject: CHEBI:94805

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:94805

object_name: endometrial cancer


subject: CHEBI:94805

object_name: endometrial carcinoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Breakthrough pain


subject: CHEBI:119915

object_name: Gastrostomy site


subject: CHEBI:119915

object_name: upper aerodigestive tract neoplasm


subject: MESH:C489164

subject_name: UltraEZ

object_name: dentin sensitivity


subject: CHEBI:135962

subject_name: Dapoxetine

object_name: Safety Issues


subject: PUBCHEM.COMPOUND:6093437


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:85994

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:85994

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:85994

object_name: Advanced Gastric Adenocarcinoma


subject: CHEBI:85994

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:85994

object_name: Unresectable Gastric Adenocarcinoma


subject: CHEBI:85994

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Advanced Gastric Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Unresectable Gastric Adenocarcinoma


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:125628

subject_name: Alisertib

object_name: atypical teratoid rhabdoid tumor


subject: CHEBI:125628

object_name: rhabdoid tumor


subject: CHEBI:31355

subject_name: Carboplatin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Optic Nerve Injuries


subject: PR:000007332

subject_name: Fanconi anemia group C protein

object_name: diabetic macular edema


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic urothelial carcinoma


subject: UMLS:C3827082


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3367

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: UMLS:C4086713

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C1541530

object_name: Advanced cancer


subject: UMLS:C1541530

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:75163792

subject_name: Ibrexafungerp

object_name: Mycoses


subject: UMLS:C0915629

subject_name: epidermal growth factor receptor VIII

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C0915629

object_name: Recurrent Glioblastoma


subject: DRUGBANK:DB05173

object_name: NF2-related schwannomatosis


subject: DRUGBANK:DB05173

object_name: vestibular schwannomatosis


subject: CHEBI:6129

subject_name: Ketorolac

object_name: diabetic retinopathy


subject: UMLS:C1366263

subject_name: Hyperimmune Colostrum, Bovine

object_name: alcoholic hepatitis


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: Hand eczema


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:174428


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:67040

subject_name: Ademetionine


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227

object_name: gastric adenocarcinoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:5931

subject_name: insulin human

object_name: Diabetic foot ulcer


subject: UMLS:C0876064

subject_name: Lantus


subject: CHEBI:3638

subject_name: Chloroquine

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:3638

object_name: metabolic syndrome X


subject: CHEBI:3638

object_name: Prediabetes


subject: CHEBI:3638

object_name: hypertension


subject: CHEBI:3638

object_name: Hypertension, CTCAE


subject: CHEBI:3638

object_name: Dyslipidemia


subject: CHEBI:3638

object_name: Overweight


subject: CHEMBL.COMPOUND:CHEMBL5095381

subject_name: RECATICIMAB

object_name: Intracranial Atherosclerosis


subject: UMLS:C5446789

subject_name: Recaticimab


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:9150

subject_name: Simvastatin


subject: UMLS:C5964783

object_name: sickle cell disease


subject: CHEBI:75929

object_name: bipolar disorder


subject: CHEBI:40009

subject_name: Cycloserine


subject: MESH:C000730795

object_name: no feeling or sensation of skin


subject: MESH:C000730795

object_name: Sensory Loss


subject: CHEBI:28864

subject_name: Tobramycin

object_name: Pseudomonas aeruginosa infection


subject: DRUGBANK:DB17574

object_name: acute leukemia


subject: DRUGBANK:DB17574

object_name: acute leukemia of ambiguous lineage


subject: DRUGBANK:DB17574

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB17574

object_name: acute myeloid leukemia


subject: DRUGBANK:DB17574

object_name: acute lymphoblastic leukemia


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: CHEBI:143658


subject: CHEBI:143658


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: childhood germ cell tumor


subject: UNII:M487QF2F4V

object_name: ovarian cancer


subject: UNII:M487QF2F4V

object_name: ovarian neoplasm


subject: UNII:M487QF2F4V

object_name: ovarian carcinoma


subject: UNII:M487QF2F4V

object_name: retinoblastoma


subject: UNII:M487QF2F4V

object_name: renal carcinoma


subject: UNII:M487QF2F4V

object_name: kidney neoplasm


subject: UNII:M487QF2F4V

object_name: kidney cancer


subject: UNII:M487QF2F4V

object_name: Childhood Neuroblastoma


subject: UNII:M487QF2F4V

object_name: neuroblastoma


subject: UNII:M487QF2F4V

object_name: liver cancer


subject: UNII:M487QF2F4V

object_name: liver neoplasm


subject: UNII:M487QF2F4V

object_name: Adult Liver Carcinoma


subject: UNII:M487QF2F4V

object_name: liver carcinoma


subject: UNII:M487QF2F4V

object_name: chordoma


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570

object_name: malignant soft tissue neoplasm


subject: CHEBI:9570

object_name: sarcoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Delirium in old age


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Acne inversa


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: Drug Interactions


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEMBL.COMPOUND:CHEMBL5095287

subject_name: ROSNILIMAB

object_name: rheumatoid arthritis


subject: UMLS:C5670503

subject_name: Rosnilimab


subject: UMLS:C1721343

subject_name: dorzolamide / timolol

object_name: OPTN-related open angle glaucoma


subject: UNII:5Q6TZN2HNM

subject_name: Ecallantide

object_name: Blood Loss


subject: UNII:5Q6TZN2HNM

object_name: Hemorrhage


subject: UMLS:C4733596

subject_name: STING Agonist MK-2118

object_name: adult lymphoma


subject: UMLS:C4733596

object_name: lymphoma


subject: UMLS:C4733596

object_name: pediatric lymphoma


subject: UMLS:C4733596

object_name: Childhood Solid Neoplasm


subject: UMLS:C4733596

object_name: Adult Solid Neoplasm


subject: UMLS:C4733596

object_name: Solid Neoplasm


subject: CHEBI:141441

subject_name: Ile-Thr


subject: CHEBI:141441


subject: CHEBI:141441


subject: CHEBI:141441


subject: CHEBI:141441


subject: CHEBI:141441


subject: CHEBI:33330

subject_name: scandium atom


subject: CHEBI:33330


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: PR:000050188


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: transposition of the great arteries


subject: CHEBI:16480

object_name: Low Cardiac Output Syndrome


subject: CHEBI:82978

subject_name: paliperidone

object_name: Compulsion


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: UMLS:C2827706

subject_name: Buprenorphine Transdermal Matrix Patch

object_name: cancer


subject: UMLS:C2827706

object_name: neoplasm


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: adult glioblastoma


subject: CHEBI:91450

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:91450

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:91450

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:91450

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:91450

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:91450


subject: CHEBI:91450

object_name: endometrial serous adenocarcinoma


subject: CHEBI:91450

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:91450

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:91450

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:91450

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:91450

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:91450

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:91450

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:91450

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91450

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91450

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91450

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:91450

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:91450

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:91450

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:66903

subject_name: Vismodegib

object_name: skin neoplasm


subject: CHEBI:66903

object_name: skin cancer


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: genetic disease


subject: UNII:D7RD81HE4W

object_name: metabolic disease


subject: UNII:D7RD81HE4W

object_name: Primary malignant neoplasm


subject: UNII:D7RD81HE4W

object_name: cancer


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:135919

subject_name: Nesiritide

object_name: diastolic heart failure


subject: CHEBI:135919

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:135919

object_name: Acute heart failure


subject: CHEBI:135919

object_name: heart disorder


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: carcinoma of esophagus


subject: UMLS:C3884609

object_name: Familial hypercholesterolemia - heterozygous


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Relapsed/refractory multiple myeloma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:9G2MP84A8W

object_name: prostate carcinoma


subject: UNII:9G2MP84A8W

object_name: prostate cancer


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: spinal cord injury


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Relapse multiple myeloma


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: urolithiasis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab

object_name: cutaneous lupus erythematosus


subject: CHEBI:6754

subject_name: Meperidine

object_name: anesthesia; adverse effect, spinal and epidural


subject: CHEBI:184693

subject_name: GRANISETRON


subject: UMLS:C3642267

subject_name: Astragalus-based Formulation Qing Shu Yi Qi Tang

object_name: non-small cell lung carcinoma


subject: UMLS:C3849154

subject_name: cheongseoikki-tang


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: NFE2L2 Gene Mutation


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: Left ventricular hypertrophy


subject: CHEBI:6503

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:73005958

object_name: Marginal zone lymphoma refractory


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Nausea, CTCAE_5


subject: CHEBI:8093

object_name: Nausea


subject: CHEBI:8093

object_name: Nausea, CTCAE_3


subject: CHEBI:49956

subject_name: Xenon

object_name: colorectal cancer


subject: CHEBI:49956

object_name: colorectal carcinoma


subject: CHEBI:49956

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:85048876

subject_name: Atripla

object_name: HIV-1 infection


subject: CHEBI:47381

subject_name: Diclofenac

object_name: knee pain chronic


subject: CHEBI:39867

subject_name: Valproic acid

object_name: schizoaffective disorder


subject: CHEBI:39867

object_name: schizophrenia 18


subject: UMLS:C0879430

object_name: ovarian cancer


subject: UMLS:C0879430

object_name: ovarian neoplasm


subject: UMLS:C0879430

object_name: ovarian carcinoma


subject: UMLS:C0879430

object_name: Childhood Breast Carcinoma


subject: UMLS:C0879430

object_name: breast carcinoma


subject: UMLS:C0879430

object_name: breast cancer


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: ovarian granulosa cell tumor


subject: CHEBI:143658

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:143658

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:143658

object_name: Malignant Solid Neoplasm


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Adult Type Granulosa Cell Tumor


subject: CHEBI:6413

subject_name: Letrozole


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: High Risk Acute Lymphoblastic Leukemia


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: metastatic malignant neoplasm in the brain


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:4614

subject_name: Dimethyl trisulfide

object_name: multiple sclerosis


subject: CHEBI:4608

subject_name: dimethyl disulfide


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: Coronavinae infectious disease


subject: UMLS:C0021027

object_name: ventilator-associated pneumonia


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: benign neoplasm of cornea


subject: UMLS:C3540708

object_name: corneal disease


subject: UMLS:C3540708

object_name: cornea cancer


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Childhood Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:49900

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab


subject: UNII:8GZG754X6M

object_name: acute promyelocytic leukemia


subject: UNII:8GZG754X6M


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:15367


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: UMLS:C0960815

object_name: HIV infection


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Brain Stem Glioblastoma


subject: UMLS:C2346820


subject: UNII:02E00T2QDE

subject_name: Eftrenonacog alfa

object_name: hemophilia B


subject: UNII:02E00T2QDE

object_name: hemophilia B leyden


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: neoplasm of esophagus


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:17568

subject_name: Uracil


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: sickle cell disease


subject: CHEBI:16867

subject_name: D-Methionine

object_name: Low back pain


subject: PUBCHEM.COMPOUND:9549299

subject_name: EGFR inhibitor

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:9549299

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:9549299

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:9549299

object_name: non-small cell lung carcinoma


subject: UMLS:C5574906

subject_name: Epidermal growth factor receptor inhibitor


subject: UMLS:C5574906


subject: UMLS:C5574906


subject: DRUGBANK:DB17478


subject: DRUGBANK:DB17478


subject: DRUGBANK:DB17478


subject: UMLS:C5908211

subject_name: KRAS G12C Inhibitor


subject: UMLS:C5908211


subject: UMLS:C5908211


subject: UMLS:C5908211


subject: UMLS:C0962969

subject_name: RAD 001

object_name: cancer


subject: UMLS:C0962969

object_name: neoplasm


subject: UMLS:C5206710


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: ovarian ectopic pregnancy


subject: UMLS:C0971731


subject: CHEBI:9434

subject_name: Telmisartan

object_name: Insulin resistance


subject: MESH:C000708971

subject_name: genexol-PM

object_name: pancreatic neoplasm


subject: MESH:C000708971

object_name: exocrine pancreatic carcinoma


subject: MESH:C000708971

object_name: malignant pancreatic neoplasm


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: Pulmonary arterial hypertension associated with portal hypertension


subject: CHEBI:71940

subject_name: Tadalafil


subject: CHEBI:71940

object_name: liver cirrhosis


subject: CHEBI:49828

subject_name: Praseodymium

object_name: Myotonia


subject: CHEBI:73645

subject_name: Pro-Arg


subject: CHEBI:8645

subject_name: purpurin


subject: CHEBI:26308

subject_name: propyl group


subject: PR:000016426

subject_name: voltage-dependent calcium channel gamma-like subunit


subject: UMLS:C0034833

subject_name: Receptors, Progesterone


subject: PR:000012621

subject_name: progesterone receptor


subject: UMLS:C2365506

subject_name: PR Otic


subject: CHEBI:6916

subject_name: Mexiletine


subject: CHEBI:74061

subject_name: Ile-Arg


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109402


subject: UMLS:C2703144


subject: GTOPDB:12652

subject_name: magrolimab

object_name: Recurrent Acute Myeloid Leukemia


subject: GTOPDB:12652

object_name: Refractory acute myeloid leukemia


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: fetal alcohol spectrum disorder


subject: CHEBI:127342

object_name: fetal alcohol syndrome


subject: CHEBI:127342

object_name: Fetus or newborn affected by alcohol transmitted via placenta or breast milk


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: COPD, severe early onset


subject: UNII:0K5743G68X

object_name: chronic obstructive pulmonary disease


subject: UNII:0K5743G68X

object_name: obstructive sleep apnea syndrome


subject: UNII:0K5743G68X

object_name: respiratory system disorder


subject: PUBCHEM.COMPOUND:154728220

object_name: Chronic low back pain


subject: UNII:TNM7KA4LB3


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: End stage cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Carcinoma breast stage IV


subject: UNII:2Y3T5IF01Z

object_name: breast neoplasm


subject: UNII:2Y3T5IF01Z


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4687432

subject_name: Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM


subject: UMLS:C4687432

object_name: Childhood Breast Carcinoma


subject: UMLS:C4687432

object_name: breast carcinoma


subject: UMLS:C4687432

object_name: breast cancer


subject: UMLS:C4687432


subject: UMLS:C4687432


subject: CHEBI:35812

subject_name: Oxfendazole

object_name: fascioliasis


subject: CHEBI:15891

subject_name: Taurine

object_name: Stomach cancer


subject: CHEBI:15891

object_name: gastric cancer


subject: UMLS:C1744162

subject_name: RPL 554

object_name: asthma


subject: UNII:2TRH1EX32K

object_name: Childhood Solid Neoplasm


subject: UNII:2TRH1EX32K

object_name: Adult Solid Neoplasm


subject: UNII:2TRH1EX32K

object_name: Solid Neoplasm


subject: UMLS:C2827547


subject: UMLS:C2827547


subject: UMLS:C2827547


subject: DRUGBANK:DB17922

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: DRUGBANK:DB17922

object_name: amyotrophic lateral sclerosis


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Metastatic Cutaneous Melanoma


subject: UNII:M487QF2F4V

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:M487QF2F4V

object_name: metastatic melanoma


subject: UNII:M487QF2F4V

object_name: Stage IV Renal Cell Cancer


subject: UNII:M487QF2F4V

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:M487QF2F4V

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:M487QF2F4V

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:M487QF2F4V

object_name: Renal cell carcinoma recurrent


subject: UNII:M487QF2F4V

object_name: Renal cancer recurrent


subject: UNII:M487QF2F4V

object_name: Melanoma recurrent


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UNII:9J13XU96Z1

subject_name: Azenosertib

object_name: endometrial serous adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Uterine carcinoma


subject: UNII:9J13XU96Z1

object_name: uterine cancer


subject: UNII:9J13XU96Z1

object_name: tumor of uterus


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: Menopause present (finding)


subject: CHEBI:135925

object_name: Menopause


subject: UMLS:C5192901

subject_name: Capsaicin 179 mg cutaneous patch

object_name: neuralgia


subject: UMLS:C5192901

object_name: Neuropathic pain


subject: UMLS:C5192901

object_name: osteoarthritis, hand


subject: UMLS:C1136254

subject_name: Microbicides

object_name: urinary tract infection


subject: UMLS:C1136254

object_name: Recurrent urinary tract infections


subject: UMLS:C5399717

subject_name: Antimicrobial [APC]


subject: UMLS:C5399717


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: adrenal carcinoma


subject: PUBCHEM.COMPOUND:21879648

object_name: adrenal cortex carcinoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Cushing syndrome


subject: PUBCHEM.COMPOUND:21879648

object_name: adrenal gland hyperfunction


subject: PUBCHEM.COMPOUND:21879648

object_name: hyperaldosteronism


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: lamellar ichthyosis


subject: CHEBI:6067

object_name: inherited ichthyosis


subject: CHEBI:6067

object_name: Congenital ichthyosiform erythroderma


subject: UNII:85KUE857XM

subject_name: SHR-1258 dimaleate

object_name: Carcinoma breast stage IV


subject: UMLS:C5206643

subject_name: Pyrotinib Dimaleate


subject: CHEBI:32682

subject_name: L-argininium

object_name: Presbyvestibulopathy


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: MESH:C559688

object_name: metastatic colorectal cancer


subject: UMLS:C3864917

subject_name: Interleukin-6 Antagonist


subject: UMLS:C3864917

object_name: Critical Illness


subject: CHEBI:10033

subject_name: Warfarin

object_name: complication


subject: GTOPDB:13795

subject_name: tagitanlimab

object_name: PD-L1 Overexpression


subject: GTOPDB:13795

object_name: PD-L1 Positive


subject: UNII:GUY458P83P

subject_name: TAGITANLIMAB


subject: UNII:GUY458P83P


subject: UMLS:C0254503


subject: UMLS:C0254503


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: uveitis


subject: UNII:N5UK68MGDZ

object_name: Uveitis, CTCAE


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:64153

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:64153

object_name: metastatic melanoma


subject: CHEBI:64153

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:64153

object_name: Melanoma recurrent


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: UMLS:C3899995

subject_name: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes

object_name: myxoid liposarcoma


subject: UMLS:C3899995

object_name: myxoid/round cell liposarcoma


subject: UMLS:C3899995

object_name: Adult Synovial Sarcoma


subject: UMLS:C3899995

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C3899995

object_name: Stage IV adult soft tissue sarcoma


subject: UMLS:C3899995

object_name: stage III adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:166822065

object_name: Unresectable Solid Neoplasm


subject: PUBCHEM.COMPOUND:166822065

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: CHEBI:16412

subject_name: Lysophosphotidylserine

object_name: Immune System Finding


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: CHEBI:58097

object_name: Right Ventricular Dysfunction


subject: CHEBI:58097

object_name: Right Ventricular Dysfunction, CTCAE


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: UNII:P0R64C4CR9

subject_name: PIXANTRONE DIMALEATE

object_name: adult lymphoma


subject: UNII:P0R64C4CR9

object_name: lymphoma


subject: UNII:P0R64C4CR9

object_name: pediatric lymphoma


subject: UNII:P0R64C4CR9

object_name: leukemia


subject: UNII:P0R64C4CR9

object_name: childhood leukemia


subject: CHEBI:135945

subject_name: Pixantrone


subject: CHEBI:135945


subject: UMLS:C2826149

subject_name: Pixantrone dimaleate


subject: UMLS:C2826149


subject: UMLS:C2826149


subject: UMLS:C2826149


subject: UMLS:C2826149


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Decreased cardiac output


subject: CHEBI:28918

object_name: Increased cardiac output


subject: CHEBI:28918

object_name: Complication of perfusion


subject: UMLS:C1174389

object_name: lung cancer


subject: UMLS:C1174389

object_name: lung neoplasm


subject: UMLS:C1174389

object_name: lung carcinoma


subject: UMLS:C3886520

object_name: Huntington disease


subject: CHEBI:84363

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:84363

object_name: Postprandial hyperglycemia


subject: CHEBI:84363

object_name: Heart Disease Risk Factors


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: CHEBI:2376


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Primary malignant neoplasm


subject: UNII:2285XW22DR

object_name: cancer


subject: UNII:2285XW22DR

object_name: childhood malignant neoplasm


subject: UNII:2285XW22DR

object_name: Malignant obstetric neoplasm


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEMBL.COMPOUND:CHEMBL4594557

subject_name: EFTILAGIMOD ALFA

object_name: Childhood Soft Tissue Sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4594557

object_name: Adult Soft Tissue Sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4594557

object_name: sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4594557

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4594557

object_name: soft tissue sarcoma


subject: UMLS:C1739076


subject: UMLS:C1739076


subject: UMLS:C1739076


subject: UMLS:C1739076


subject: UMLS:C1739076


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:9570

subject_name: Thiotepa


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Renal cell carcinoma recurrent


subject: CHEBI:4026

object_name: Renal cancer recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: Knee arthropathy


subject: UMLS:C5782829

object_name: Arthritis of knee


subject: UMLS:C5782829

object_name: knee pain chronic


subject: UMLS:C5782829

object_name: osteoarthritis, knee


subject: GTOPDB:9615

object_name: chordoma


subject: GTOPDB:9615

object_name: Unresectable Malignant Neoplasm


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UNII:S098K6HGD9


subject: UNII:S098K6HGD9


subject: UMLS:C4684904

subject_name: Aldoxorubicin Hydrochloride


subject: UMLS:C4684904


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C5777124


subject: UMLS:C4552849

subject_name: haNK


subject: UMLS:C4552849


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Medication interaction potentiation


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:8JXN261VVA


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:71954

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: temporomandibular joint disorder


subject: UNII:IVJ88KQ4XN

subject_name: tanshinone II A sodium sulfonate

object_name: acute myocardial infarction


subject: UNII:IVJ88KQ4XN

object_name: Acute Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:2269

object_name: chlamydia


subject: PUBCHEM.COMPOUND:2269

object_name: chlamydia infectious disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C1832026

object_name: non-small cell lung carcinoma


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1


subject: CHEBI:28741

subject_name: Sodium fluoride

object_name: tooth erosion


subject: PUBCHEM.COMPOUND:11464175

subject_name: trovafloxacin

object_name: staphylococcus aureus infection


subject: PUBCHEM.COMPOUND:11464175

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:11464175

object_name: Bacteremia, CTCAE


subject: PUBCHEM.COMPOUND:11464175

object_name: endocarditis


subject: PUBCHEM.COMPOUND:11464175

object_name: Sepsis


subject: PUBCHEM.COMPOUND:11464175

object_name: Sepsis, CTCAE


subject: CHEBI:9763

subject_name: Trovafloxacin


subject: CHEBI:9763


subject: CHEBI:9763


subject: CHEBI:9763


subject: CHEBI:9763


subject: CHEBI:9763


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: UNII:6GNT3Y5LMF


subject: UNII:6GNT3Y5LMF


subject: UNII:6GNT3Y5LMF


subject: UNII:6GNT3Y5LMF


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:39048

subject_name: ADA

object_name: rheumatoid arthritis


subject: UMLS:C5399992

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib


subject: PUBCHEM.COMPOUND:77256380

object_name: Treatment related acute myeloid leukaemia


subject: PUBCHEM.COMPOUND:77256380

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:5941

subject_name: Intermedine

object_name: acute kidney failure


subject: CHEBI:195325

subject_name: alpha-MSH


subject: UMLS:C0002302


subject: CHEBI:9123

subject_name: Sertraline

object_name: separation anxiety disorder


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab

object_name: Adult Acute Promyelocytic Leukemia


subject: UNII:8GZG754X6M

object_name: Childhood Acute Promyelocytic Leukemia


subject: UNII:8GZG754X6M

object_name: recurrent childhood acute myeloid leukemia


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C4548896

object_name: adult dermatomyositis


subject: UMLS:C4548896

object_name: dermatomyositis


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: graft versus host disease


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: asthma


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Hormone receptor positive malignant neoplasm of breast


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Locally advanced breast cancer


subject: UNII:28X28X9OKV

object_name: Malignant neoplasm of female breast


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:KZ3DLD11RQ

object_name: Childhood Breast Carcinoma


subject: UNII:KZ3DLD11RQ

object_name: breast carcinoma


subject: UNII:KZ3DLD11RQ

object_name: breast cancer


subject: UMLS:C4733572

subject_name: Synthetic Plumbagin PCUR-101

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:52717

subject_name: Bortezomib

object_name: acquired thrombotic thrombocytopenic purpura


subject: GTOPDB:9109

object_name: melanoma


subject: UMLS:C3273043


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: HIV infection


subject: UMLS:C4727559

object_name: non-small cell lung carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:6129

object_name: clear cell renal carcinoma


subject: CHEBI:6129

object_name: renal cell adenocarcinoma


subject: CHEBI:6129

object_name: renal cell carcinoma


subject: CHEBI:78425

subject_name: Albiglutide

object_name: diabetes mellitus


subject: UMLS:C1299007

subject_name: alpha-Glucosidase Inhibitors


subject: UMLS:C2267008

subject_name: alpha-Glucosidase Inhibitor [EPC]


subject: UMLS:C3537187

subject_name: Biguanide [EPC]


subject: UMLS:C2266929

subject_name: Glinide [EPC]


subject: CHEBI:50992


subject: UMLS:C3537039

subject_name: Thiazolidinedione [EPC]


subject: UMLS:C5418055

subject_name: Glutamine Antagonist DRP-104

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5418055

object_name: Metastatic non-small cell lung cancer


subject: UNII:0OOS09O1FH

subject_name: NADOFARAGENE FIRADENOVEC

object_name: superficial urinary bladder carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Tremor


subject: CHEBI:4466

object_name: Tremor, CTCAE_5


subject: CHEBI:4466

object_name: Tremor, CTCAE_3


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:135402036

object_name: Recurrent Low Back Pain


subject: PUBCHEM.COMPOUND:135402036

object_name: cancer pain


subject: PUBCHEM.COMPOUND:135402036

object_name: osteoarthritis


subject: CHEBI:17202

subject_name: Inosinic Acid


subject: CHEBI:17202


subject: CHEBI:17202


subject: CHEBI:58053


subject: CHEBI:58053


subject: CHEBI:58053


subject: CHEBI:190509

subject_name: Imipenem


subject: CHEBI:190509


subject: CHEBI:190509


subject: PUBCHEM.COMPOUND:54026825

subject_name: Glucoseamine

object_name: osteoarthritis, knee


subject: UMLS:C0939309

subject_name: Depakote ER

object_name: borderline personality disorder


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: urothelial carcinoma


subject: UNII:QA3Y8EZG57

subject_name: Ivaltinostat

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:4I8MLM7L2H


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: nonpapillary renal cell carcinoma


subject: UNII:768FW21J3L

object_name: clear cell renal carcinoma


subject: UNII:768FW21J3L

object_name: renal cell adenocarcinoma


subject: UNII:768FW21J3L

object_name: renal cell carcinoma


subject: UNII:768FW21J3L

object_name: cervical cancer


subject: UNII:768FW21J3L

object_name: cervical carcinoma


subject: UNII:768FW21J3L

object_name: Recurrent ovarian cancer


subject: UNII:768FW21J3L


subject: UNII:768FW21J3L

object_name: transitional cell carcinoma


subject: UNII:768FW21J3L

object_name: endometrial cancer


subject: UNII:768FW21J3L

object_name: uterine corpus cancer


subject: UNII:768FW21J3L

object_name: endometrial carcinoma


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:D07V79Q44T

object_name: colorectal cancer


subject: UNII:D07V79Q44T

object_name: colorectal carcinoma


subject: UNII:D07V79Q44T

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: epicondylitis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: PR:000017019

object_name: acute respiratory distress syndrome


subject: PR:000017019

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: PR:000017019

object_name: adult acute respiratory distress syndrome


subject: UMLS:C4042301

subject_name: Longidaza

object_name: bacterial vaginosis


subject: GTOPDB:3545

subject_name: urocortin 2

object_name: heart failure


subject: GTOPDB:3545

object_name: Heart Failure, CTCAE


subject: UMLS:C0969397

subject_name: urocortin II


subject: UMLS:C0969397


subject: GTOPDB:928

subject_name: urocortin 3


subject: GTOPDB:928


subject: UMLS:C0967953

subject_name: urocortin III


subject: UMLS:C0967953


subject: CHEBI:190692

subject_name: substance P(3+)


subject: CHEBI:190692


subject: CHEBI:80308

subject_name: substance P


subject: CHEBI:80308


subject: UNII:675VGV5J1D

subject_name: SUBSTANCE P


subject: UNII:675VGV5J1D


subject: UMLS:C0038585

subject_name: Substance P


subject: UMLS:C0038585


subject: UMLS:C2976524

subject_name: KRN 951

object_name: Solid Neoplasm


subject: CHEBI:91327

subject_name: Tivozanib


subject: CHEBI:231347

subject_name: Triapine

object_name: Stage II Cervical Cancer AJCC v7


subject: CHEBI:231347

object_name: Stage IB2 Cervical Cancer


subject: CHEBI:231347

object_name: vaginal carcinoma


subject: CHEBI:231347

object_name: Stage IV Vaginal Cancer AJCC v6 and v7


subject: CHEBI:231347

object_name: Advanced Vaginal Adenocarcinoma


subject: CHEBI:231347

object_name: Advanced Vaginal Squamous Cell Carcinoma


subject: CHEBI:231347

object_name: Advanced Vaginal Adenosquamous Carcinoma


subject: CHEBI:231347

object_name: cervical adenocarcinoma


subject: CHEBI:231347

object_name: cervical squamous cell carcinoma


subject: CHEBI:231347

object_name: Unresectable Vaginal Carcinoma


subject: CHEBI:231347

object_name: vaginal adenocarcinoma


subject: CHEBI:231347

object_name: cervical adenosquamous carcinoma


subject: CHEBI:231347

object_name: Vaginal Adenosquamous Carcinoma


subject: CHEBI:231347

object_name: vaginal squamous cell carcinoma


subject: UMLS:C4045875

object_name: rheumatoid arthritis


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Estrogen receptor positive tumor


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid


subject: CHEBI:63587

subject_name: Eribulin


subject: PUBCHEM.COMPOUND:9914270

subject_name: Landiolol

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:9914270

object_name: Acute heart failure


subject: PUBCHEM.COMPOUND:9914270

object_name: Rapid atrial fibrillation


subject: PUBCHEM.COMPOUND:9914270

object_name: Abnormal left ventricular function


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:23667621

object_name: ureterolithiasis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:6149

subject_name: Levobupivacaine


subject: CHEBI:85993

subject_name: Palbociclib

object_name: esophageal squamous cell carcinoma


subject: CHEBI:75551


subject: CHEBI:3175

subject_name: Brimonidine

object_name: Seasonal allergic conjunctivitis


subject: CHEBI:91248

subject_name: L-cysteine hydrochloride hydrate

object_name: erythropoietic protoporphyria


subject: CHEBI:91248

object_name: protoporphyria, erythropoietic, 1


subject: PUBCHEM.COMPOUND:53395091


subject: PUBCHEM.COMPOUND:53395091


subject: CHEBI:16375

subject_name: D-Cysteine


subject: CHEBI:16375


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: UMLS:C0724565

subject_name: cysteine hydrochloride


subject: UMLS:C0724565


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Nocturnal hypertension


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Migrainous vertigo


subject: CHEBI:34385

object_name: vestibular disorder


subject: CHEBI:34385

object_name: migraine


subject: CHEBI:55352

subject_name: (R)-Atenolol


subject: CHEBI:55352


subject: CHEBI:55352


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:2904


subject: CHEBI:2904


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: colon cancer


subject: UMLS:C5417876

subject_name: Cedazuridine/Azacitidine Combination Agent ASTX030

object_name: Myelodysplasia


subject: CHEBI:15864

subject_name: Luteolin

object_name: Memory observations


subject: CHEBI:57545


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: Hypoxemia


subject: CHEBI:78870

object_name: Hypoxia, CTCAE


subject: CHEBI:78870

object_name: cardiovascular disorder


subject: CHEBI:78870

object_name: Vasodilation disorder


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: triple-negative breast carcinoma


subject: GTOPDB:4942

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: CHEMBL.COMPOUND:CHEMBL3833386

subject_name: GALINPEPIMUT-S

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL3833386

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3833386

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3833386

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL3833386

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3833386

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL3833386


subject: CHEMBL.COMPOUND:CHEMBL3833386


subject: UMLS:C5206092

subject_name: Galinpepimut-S


subject: UMLS:C5206092


subject: UMLS:C5206092


subject: UMLS:C5206092


subject: UMLS:C5206092


subject: UMLS:C5206092


subject: UMLS:C5206092


subject: UMLS:C5206092


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Kaposi Sarcoma


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IVA Lung Cancer AJCC v8


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Post transplant diabetes mellitus


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: autoimmune encephalitis


subject: MESH:C551853

subject_name: Viusid

object_name: respiratory system disorder


subject: MESH:C551853

object_name: Immune System Finding


subject: UMLS:C4085979

object_name: cholangiocarcinoma


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: biliary tract cancer


subject: UMLS:C0521939

subject_name: Selenium supplement

object_name: pervasive developmental disorder


subject: UMLS:C0521939

object_name: autism


subject: UMLS:C0521939

object_name: autism spectrum disorder


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: fallopian tube carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: fallopian tube cancer


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: high grade ovarian serous adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: primary peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: papillary serous cystadenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594486

object_name: peritoneal carcinoma


subject: UMLS:C5417995

subject_name: Gotistobart


subject: UMLS:C5417995


subject: UMLS:C5417995


subject: UMLS:C5417995


subject: UMLS:C5417995


subject: UMLS:C5417995


subject: UMLS:C5417995


subject: UMLS:C5417995


subject: UMLS:C5417995


subject: PUBCHEM.COMPOUND:122316

object_name: Presenile dementia


subject: PUBCHEM.COMPOUND:122316

object_name: dementia


subject: CHEBI:63620

subject_name: Rasagiline


subject: CHEBI:63620


subject: UMLS:C5205034

object_name: renal cell carcinoma


subject: UniProtKB:Q00495

subject_name: CSF1R_RAT Macrophage colony-stimulating factor 1 receptor (sprot)

object_name: Oral Epithelial Dysplasia


subject: UniProtKB:Q00495

object_name: Leukokeratosis


subject: PR:000002062

subject_name: macrophage colony-stimulating factor 1 receptor


subject: PR:000002062


subject: UniProtKB:P0A6K3

subject_name: DEF_ECOLI Peptide deformylase (sprot)


subject: UniProtKB:P0A6K3


subject: PR:000022424

subject_name: peptide deformylase


subject: PR:000022424


subject: PUBCHEM.COMPOUND:90877554

object_name: mild neurocognitive disorder


subject: PUBCHEM.COMPOUND:90877554

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:90877554

object_name: Huntington disease


subject: PUBCHEM.COMPOUND:90877554

object_name: fragile X syndrome


subject: PUBCHEM.COMPOUND:90877554

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:90877554

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:90877554

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:90877554

object_name: autism spectrum disorder


subject: UMLS:C2351846


subject: UMLS:C2351846


subject: UMLS:C2351846


subject: UMLS:C2351846


subject: UMLS:C2351846


subject: UMLS:C2351846


subject: UMLS:C2351846


subject: UMLS:C2351846


subject: CHEBI:119915

subject_name: Fentanyl

object_name: peripheral vascular disease


subject: CHEBI:60802

subject_name: ropivacaine


subject: PUBCHEM.COMPOUND:66586232

object_name: periprosthetic joint infection


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: UMLS:C5555778

subject_name: Bcl-2 Inhibitor LOXO-338

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5555778

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C5555778

object_name: marginal zone lymphoma


subject: UMLS:C5555778

object_name: MALT lymphoma


subject: UMLS:C5555778

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5555778

object_name: non-Hodgkin lymphoma


subject: UMLS:C5555778

object_name: mantle cell lymphoma


subject: UMLS:C5555778

object_name: plasma cell myeloma


subject: UMLS:C5555778

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5555778

object_name: B-cell neoplasm


subject: CHEBI:229212

subject_name: Pirtobrutinib


subject: CHEBI:229212


subject: CHEBI:229212


subject: CHEBI:229212


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Injection site irritation


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Acute Respiratory Distress


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C5667096

subject_name: Oncolytic HSV-1 Expressing IL-12 and IL-15/IL-15-receptor Alpha VG2025

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5667096

object_name: Carcinomatosis


subject: UMLS:C5667096

object_name: carcinomatosis of unspecified behavior


subject: CHEMBL.COMPOUND:CHEMBL2109534

object_name: neoplasm


subject: UMLS:C2984514


subject: UMLS:C0066889

subject_name: MT-I

object_name: erythropoietic protoporphyria


subject: UMLS:C0066889

object_name: protoporphyria, erythropoietic, 1


subject: GTOPDB:5026

subject_name: NGF

object_name: cancer pain


subject: UMLS:C0003241

subject_name: Antibodies


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: UMLS:C5554914

subject_name: Dalnicastobart

object_name: cancer


subject: UMLS:C5554914


subject: CHEBI:61917

subject_name: (R)-thalidomide

object_name: colorectal neoplasm


subject: CHEBI:61918

subject_name: (S)-thalidomide


subject: CHEBI:28487

subject_name: Reserpine

object_name: cocaine abuse


subject: CHEBI:28487

object_name: substance-related disorder


subject: CHEBI:231683

subject_name: Anakinra

object_name: inclusion body myositis


subject: CHEBI:231683

object_name: polymyositis


subject: CHEBI:231683

object_name: adult dermatomyositis


subject: CHEBI:231683

object_name: dermatomyositis


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: CHEBI:10112

subject_name: Zileuton

object_name: acne


subject: UMLS:C3896796

subject_name: narsoplimab

object_name: thrombotic microangiopathy


subject: CHEBI:47898

subject_name: Epirubicin

object_name: lung adenocarcinoma


subject: CHEBI:47898

object_name: cervical adenocarcinoma


subject: CHEBI:47898

object_name: adenocarcinoma


subject: CHEBI:47898

object_name: bile duct adenocarcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: esophageal adenocarcinoma


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026

object_name: gastric adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:6456

object_name: Back pain


subject: CHEBI:6456

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:6456

object_name: arthritis


subject: CHEBI:6456

object_name: Arthritis, CTCAE


subject: GTOPDB:10659

subject_name: bempegaldesleukin

object_name: bladder tumor


subject: GTOPDB:10659

object_name: urinary bladder carcinoma


subject: GTOPDB:10659

object_name: urinary bladder cancer


subject: GTOPDB:10659

object_name: childhood bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298058

subject_name: BEMPEGALDESLEUKIN


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UNII:G5WS9R9D50

subject_name: MONOSIALOTETRAHEXOSYLGANGLIOSIDE SODIUM

object_name: colorectal cancer


subject: UNII:G5WS9R9D50

object_name: colorectal carcinoma


subject: UNII:G5WS9R9D50

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Emergence Delirium


subject: CHEBI:17045

subject_name: Nitrous oxide


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: UNII:OS7097575K

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: UNII:OS7097575K

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UNII:OS7097575K

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UNII:OS7097575K

object_name: T-Cell Lymphoma


subject: UNII:OS7097575K

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:OS7097575K

object_name: Refractory Transformed Mycosis Fungoides


subject: UNII:OS7097575K

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UNII:OS7097575K

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:OS7097575K

object_name: Recurrent Transformed Mycosis Fungoides


subject: CHEBI:61080

subject_name: Romidepsin


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:27470

subject_name: Folic acid

object_name: Dyslipidemia


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Peptic Ulcer Hemorrhage


subject: CHEBI:31206

subject_name: Chloroaminium

object_name: heart failure


subject: CHEBI:31206

object_name: Heart Failure, CTCAE


subject: CHEBI:28938

subject_name: ammonium


subject: CHEBI:28938


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: fibromatosis


subject: UNII:6T4O391P5Y

object_name: desmoid tumor


subject: UNII:6T4O391P5Y

object_name: Desmoid tumor


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: dentin sensitivity


subject: PUBCHEM.COMPOUND:157010100

object_name: periodontal disorder


subject: UMLS:C1120338

subject_name: casein phosphopeptide-amorphous calcium phosphate nanocomplex

object_name: Incipient enamel caries


subject: MESH:C510984

subject_name: NovaMin


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: recurrent acute pancreatitis


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Post-Operative Pain


subject: CHEBI:26336

subject_name: prostaglandins C

object_name: Effects of radiation


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Fatty Liver


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:3535

subject_name: Cephalexin

object_name: cellulitis


subject: CHEBI:3535

object_name: cellulitis on exam (physical finding)


subject: CHEBI:3534


subject: CHEBI:3534


subject: RXCUI:215703

subject_name: Blephamide

object_name: Posterior blepharitis


subject: CHEBI:149509

object_name: HIV infection


subject: CHEBI:3347

subject_name: Candesartan


subject: UMLS:C5667043

subject_name: Bcl-2/Bcl-XL Inhibitor LP-118

object_name: lymphoblastic lymphoma


subject: UMLS:C5667043

object_name: Adult Lymphoblastic Lymphoma


subject: UMLS:C5667043

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C5667043

object_name: lymphoid leukemia


subject: UMLS:C5667043

object_name: acute leukemia


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:78543


subject: CHEBI:78543


subject: CHEBI:78543


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: Coronavinae infectious disease


subject: CHEBI:9434

subject_name: Telmisartan


subject: CHEBI:7492

subject_name: Nedocromil

object_name: asthma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: neurotoxicity


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:6121

subject_name: Ketamine

object_name: Bronchospasm


subject: CHEBI:6121

object_name: Bronchoconstriction


subject: CHEBI:6121

object_name: Bronchospasm, CTCAE


subject: CHEBI:6121


subject: PUBCHEM.COMPOUND:2269

object_name: bronchopulmonary dysplasia


subject: PUBCHEM.COMPOUND:2269

object_name: Bronchopulmonary Dysplasia, AE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEMBL.COMPOUND:CHEMBL2109406

subject_name: PATRITUMAB

object_name: Solid Neoplasm


subject: UMLS:C3888263


subject: CHEBI:135956

subject_name: Vernakalant

object_name: atrial flutter


subject: CHEBI:135956

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:135956

object_name: Atrial Flutter, CTCAE


subject: UMLS:C2001573


subject: UMLS:C2001573


subject: UMLS:C2001573


subject: PUBCHEM.COMPOUND:72959169

subject_name: Mayzent

object_name: Multiple sclerosis relapse


subject: UNII:RR6P8L282I

subject_name: Siponimod


subject: UMLS:C0982327

subject_name: PEGINTERFERON

object_name: Liver Cirrhosis, Experimental


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: end stage renal failure


subject: CHEBI:23359

subject_name: colchicine

object_name: heart disorder


subject: CHEBI:23359

object_name: Single Ventricle Defect


subject: CHEBI:23359

object_name: Single ventricle


subject: UMLS:C3896736

subject_name: Anti-OFA Immunotherapeutic BB-MPI-03

object_name: plasma cell myeloma


subject: UMLS:C3896736

object_name: acute myeloid leukemia


subject: UMLS:C3896736

object_name: Myelodysplasia


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)


subject: MESH:C000712049


subject: MESH:C000712049


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: CHEBI:66919

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:66919

object_name: FIGO Stage III Ovarian Cancer 2014


subject: CHEBI:66919

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:66919

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:66919

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: CHEBI:66919

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:66919

object_name: FIGO Stage IIIC Ovarian Cancer


subject: CHEBI:66919

object_name: FIGO Stage IIIA Ovarian Cancer


subject: CHEBI:66919

object_name: FIGO Stage IIIB Ovarian Cancer


subject: CHEBI:66919

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:66919

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:66919

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:66919

object_name: FIGO Stage IIIA1 Ovarian Cancer


subject: CHEBI:66919

object_name: FIGO Stage IIIA2 Ovarian Cancer


subject: CHEBI:66919

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:66919

object_name: FIGO Stage IVB Ovarian Cancer 2014


subject: CHEBI:66919

object_name: FIGO Stage IVA Ovarian Cancer 2014


subject: CHEBI:66919

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:66919

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:66919

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:66919

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:66919

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:66919

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:66919

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:66919

object_name: high grade ovarian serous adenocarcinoma


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: Pre T-ALL


subject: UNII:R30772KCU0

object_name: adult T-cell leukemia/lymphoma


subject: UNII:R30772KCU0

object_name: precursor T-cell acute lymphoblastic leukemia


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Small cell lung cancer extensive stage


subject: CHEBI:177413

subject_name: Plinabulin


subject: UMLS:C1741609


subject: CHEBI:18358

subject_name: Methoxsalen

object_name: Mycosis fungoides/Sezary syndrome


subject: CHEBI:18358

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:18358

object_name: primary cutaneous T-cell lymphoma


subject: UNII:Q3NN3EB8VY

subject_name: CLOSTRIDIUM BUTYRICUM

object_name: Depressed mood


subject: UNII:Q3NN3EB8VY

object_name: Cancer patients and suicide and depression


subject: UNII:Q3NN3EB8VY

object_name: Depressed - symptom


subject: UNII:Q3NN3EB8VY

object_name: Depression, CTCAE


subject: UNII:Q3NN3EB8VY

object_name: anxiety


subject: UNII:Q3NN3EB8VY

object_name: anxiety disorder


subject: UNII:Q3NN3EB8VY

object_name: Anxiety symptoms


subject: UNII:Q3NN3EB8VY

object_name: Anxiety, CTCAE 3.0


subject: UNII:Q3NN3EB8VY

object_name: Anxiety, CTCAE 5.0


subject: UNII:Q3NN3EB8VY

object_name: Nonulcer dyspepsia


subject: GTOPDB:12361

subject_name: sabatolimab

object_name: Myelodysplasia


subject: GTOPDB:12361

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:12361

object_name: acute myeloid leukemia


subject: UNII:3L7R886Y06

subject_name: SABATOLIMAB


subject: UNII:3L7R886Y06


subject: UNII:3L7R886Y06


subject: UMLS:C4085985


subject: UMLS:C0086466

subject_name: Injectables

object_name: myocardial infarction


subject: UMLS:C0086466

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C0086466

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:6420057

subject_name: METOPROLOL TARTRATE


subject: PUBCHEM.COMPOUND:6420057


subject: PUBCHEM.COMPOUND:6420057


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:60269

subject_name: trisodium phosphonoformate hexahydrate

object_name: herpes simplex


subject: CHEBI:127780

subject_name: Foscarnet


subject: UMLS:C3541932

subject_name: Moringa oleifera extract

object_name: hereditary endocrine growth disease


subject: PUBCHEM.COMPOUND:71308244

subject_name: Naldemedine

object_name: Constipation


subject: PUBCHEM.COMPOUND:71308244

object_name: Constipation, CTCAE


subject: PUBCHEM.COMPOUND:71308244

object_name: Opioid-Induced Bowel Dysfunction


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: pseudotumor cerebri


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: contrast-induced nephropathy


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Discogenic pain


subject: CHEBI:144903

object_name: chronic pain (diagnosis)


subject: CHEBI:144903

object_name: Chronic pain


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: UMLS:C5707687

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5707687

object_name: FGFR3 Overexpression Positive


subject: UMLS:C5707687

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5707687

object_name: Stomach cancer


subject: UMLS:C5707687

object_name: gastric cancer


subject: UMLS:C5707687

object_name: colorectal cancer


subject: UMLS:C5707687

object_name: colorectal carcinoma


subject: UMLS:C5707687

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5707687

object_name: urinary bladder carcinoma


subject: UMLS:C5707687

object_name: ovarian cancer


subject: UMLS:C5707687

object_name: ovarian neoplasm


subject: UMLS:C5707687

object_name: ovarian carcinoma


subject: UMLS:C5707687

object_name: Childhood Breast Carcinoma


subject: UMLS:C5707687

object_name: breast carcinoma


subject: UMLS:C5707687

object_name: breast cancer


subject: UMLS:C5707687

object_name: liver cancer


subject: UMLS:C5707687

object_name: liver neoplasm


subject: UMLS:C5707687

object_name: Adult Liver Carcinoma


subject: UMLS:C5707687

object_name: liver carcinoma


subject: UMLS:C5707687

object_name: lung cancer


subject: UMLS:C5707687

object_name: lung neoplasm


subject: UMLS:C5707687

object_name: lung carcinoma


subject: UMLS:C5706230

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706230

object_name: FGFR3 Overexpression Positive


subject: UMLS:C5706230

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5706230

object_name: Stomach cancer


subject: UMLS:C5706230

object_name: gastric cancer


subject: UMLS:C5706230

object_name: colorectal cancer


subject: UMLS:C5706230

object_name: colorectal carcinoma


subject: UMLS:C5706230

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5706230

object_name: urinary bladder carcinoma


subject: UMLS:C5706230

object_name: ovarian cancer


subject: UMLS:C5706230

object_name: ovarian neoplasm


subject: UMLS:C5706230

object_name: ovarian carcinoma


subject: UMLS:C5706230

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706230

object_name: breast carcinoma


subject: UMLS:C5706230

object_name: breast cancer


subject: UMLS:C5706230

object_name: liver cancer


subject: UMLS:C5706230

object_name: liver neoplasm


subject: UMLS:C5706230

object_name: Adult Liver Carcinoma


subject: UMLS:C5706230

object_name: liver carcinoma


subject: UMLS:C5706230

object_name: lung cancer


subject: UMLS:C5706230

object_name: lung neoplasm


subject: UMLS:C5706230

object_name: lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

subject_name: VOFATAMAB

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: FGFR3 Overexpression Positive


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: Stomach cancer


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: urinary bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: liver cancer


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: liver neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: Adult Liver Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: lung cancer


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: lung neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297848

object_name: lung carcinoma


subject: UMLS:C3493556

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3493556

object_name: FGFR3 Overexpression Positive


subject: UMLS:C3493556

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3493556

object_name: Stomach cancer


subject: UMLS:C3493556

object_name: gastric cancer


subject: UMLS:C3493556

object_name: colorectal cancer


subject: UMLS:C3493556

object_name: colorectal carcinoma


subject: UMLS:C3493556

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3493556

object_name: urinary bladder carcinoma


subject: UMLS:C3493556

object_name: ovarian cancer


subject: UMLS:C3493556

object_name: ovarian neoplasm


subject: UMLS:C3493556

object_name: ovarian carcinoma


subject: UMLS:C3493556

object_name: Childhood Breast Carcinoma


subject: UMLS:C3493556

object_name: breast carcinoma


subject: UMLS:C3493556

object_name: breast cancer


subject: UMLS:C3493556

object_name: liver cancer


subject: UMLS:C3493556

object_name: liver neoplasm


subject: UMLS:C3493556

object_name: Adult Liver Carcinoma


subject: UMLS:C3493556

object_name: liver carcinoma


subject: UMLS:C3493556

object_name: lung cancer


subject: UMLS:C3493556

object_name: lung neoplasm


subject: UMLS:C3493556

object_name: lung carcinoma


subject: CHEBI:177298

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:177298

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: UMLS:C4287698

subject_name: Cobolimab

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4287698

object_name: Embolism, Tumor


subject: UMLS:C4287698

object_name: Neoplasm Metastasis


subject: UMLS:C4287698

object_name: Advanced cancer


subject: UMLS:C4287698


subject: UMLS:C4287698


subject: UMLS:C4287698

object_name: Childhood Solid Neoplasm


subject: UMLS:C4287698

object_name: Adult Solid Neoplasm


subject: UMLS:C4287698

object_name: Solid Neoplasm


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UNII:1A7Y9MP123

object_name: cancer


subject: UNII:1A7Y9MP123

object_name: neoplasm


subject: UMLS:C2703140


subject: UMLS:C2703140


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: schizophreniform disorder


subject: CHEBI:44915

subject_name: Propofol

object_name: complication


subject: CHEBI:9561

subject_name: Thiopental


subject: CHEBI:102166


subject: CHEBI:5062

subject_name: Finasteride

object_name: Large prostate


subject: UMLS:C2757070

subject_name: Progesterone [EPC]

object_name: female infertility


subject: CHEBI:9144

subject_name: Silibinin

object_name: Cisplatin adverse reaction


subject: CHEBI:9144

object_name: upper GI cancer


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:49140

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:49140

object_name: clear cell renal carcinoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: MESH:C000728461


subject: MESH:C000728461


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: CYP2C19 polymorphism


subject: UMLS:C1879711

subject_name: AMG 102

object_name: non-small cell lung carcinoma


subject: GTOPDB:5962

subject_name: dovitinib

object_name: Carcinoma breast stage IV


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: cytokine release syndrome


subject: CHEBI:41879

object_name: Cytokine storm


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: Uterine hemorrhage


subject: UNII:P76B05O5V6

object_name: Uterine Hemorrhage, CTCAE


subject: UNII:P76B05O5V6

object_name: uterine cancer


subject: UNII:P76B05O5V6

object_name: tumor of uterus


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate


subject: PUBCHEM.COMPOUND:541197


subject: PUBCHEM.COMPOUND:541197


subject: CHEBI:7627

subject_name: Norethisterone


subject: CHEBI:7627


subject: CHEBI:7627


subject: CHEBI:41879

object_name: Clinically significant macular edema due to diabetes mellitus


subject: UMLS:C1310928

object_name: Myelodysplasia


subject: UMLS:C1310928

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1310928

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1310928

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1310928

object_name: plasma cell myeloma


subject: UMLS:C1310928

object_name: leukemia


subject: UMLS:C1310928

object_name: childhood leukemia


subject: UMLS:C1310928

object_name: adult lymphoma


subject: UMLS:C1310928

object_name: lymphoma


subject: UMLS:C1310928

object_name: pediatric lymphoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Lewy Bodies


subject: CHEBI:85078

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Early Stage Breast Carcinoma


subject: UMLS:C0389489

subject_name: DPC 817

object_name: HIV infection


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: drug-induced liver injury


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: CHEBI:5550

subject_name: Guaiazulen


subject: CHEBI:15365

subject_name: Aspirin

object_name: aortic valve insufficiency


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: PUBCHEM.COMPOUND:129817405

subject_name: Hydroxide ZINC acetate

object_name: dystonia


subject: PUBCHEM.COMPOUND:129817405

object_name: neurodevelopmental disorder with involuntary movements


subject: PUBCHEM.COMPOUND:129817405

object_name: developmental and epileptic encephalopathy, 17


subject: PUBCHEM.COMPOUND:129817405

object_name: Developmental delay


subject: PUBCHEM.COMPOUND:129817405

object_name: Choreoathetosis


subject: PUBCHEM.COMPOUND:129817405

object_name: epilepsy


subject: UMLS:C1657541

subject_name: Zinc Acetate Dihydrate


subject: UMLS:C1657541


subject: UMLS:C1657541


subject: UMLS:C1657541


subject: UMLS:C1657541


subject: UMLS:C1657541


subject: CHEBI:94366

subject_name: itraconazole

object_name: lung transplant infection


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:GN429E725A

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: chronic thromboembolic pulmonary hypertension


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Adult Diffuse Large Cell Lymphoma


subject: CHEBI:201431

object_name: Marginal zone lymphoma refractory


subject: CHEBI:201431

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:201431

object_name: acute biphenotypic leukemia


subject: CHEBI:201431

object_name: mixed phenotype acute leukemia


subject: CHEBI:201431

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:201431

object_name: Follicular lymphoma refractory


subject: CHEBI:201431

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:201431

object_name: lymphoblastic lymphoma


subject: CHEBI:201431

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:201431

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: anaplastic large cell lymphoma


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: prolymphocytic leukemia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:9296

object_name: Marginal zone lymphoma refractory


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:9296

object_name: acute biphenotypic leukemia


subject: PUBCHEM.COMPOUND:9296

object_name: mixed phenotype acute leukemia


subject: PUBCHEM.COMPOUND:9296

object_name: acute leukemia of ambiguous lineage


subject: PUBCHEM.COMPOUND:9296

object_name: Follicular lymphoma refractory


subject: PUBCHEM.COMPOUND:9296

object_name: lymphoplasmacytic lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296

object_name: lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:9296

object_name: acute leukemia


subject: GTOPDB:4985

object_name: Childhood Solid Neoplasm


subject: GTOPDB:4985

object_name: Adult Solid Neoplasm


subject: GTOPDB:4985

object_name: Solid Neoplasm


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IB2 Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage II Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIB Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIA Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIA2 Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIA1 Cervical Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: cervical squamous cell carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C4287762

subject_name: HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:6015

subject_name: Isoflurane

object_name: CORONARY ARTERY BYPASS GRAFT TRIPLE VESSEL


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: abdominal obesity-metabolic syndrome


subject: UNII:DLG4EML025

object_name: metabolic syndrome X


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Infant, Premature, Diseases


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: intestinal atresia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: gastroschisis